Aptose Biosciences Inc (APTO):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C2730)
◆英語タイトル:Aptose Biosciences Inc (APTO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2730
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年8月
◆ページ数:50
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Aptose Biosciences Inc (APTO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aptose Biosciences Inc (Aptose) is a clinical-stage biotechnology company which focuses on diagnostics, therapies and treatment for patients with life-threatening cancers. The company advances in new therapeutics which focuses on cellular targets of cancer research coupled with companion diagnostics to identify patient with cancer. Its small molecule cancer therapeutics pipeline includes products which are designed to provide single agent efficacy and efficacy of other anti-cancer therapies and regimens without overlapping toxicities. The company’s product portfolio comprises of CG’806, is a non-covalent small molecule therapeutic agent. Aptose is headquartered in Toronto, Ontario, Canada.

Aptose Biosciences Inc Key Recent Developments

Aug 07,2018: Aptose reports results for the second quarter ended june 30, 2018
May 10,2018: Aptose Reports Results for the First Quarter Ended March 31, 2018
Apr 25,2018: Aptose Names Caroline M. Loewy As Board Director
Mar 27,2018: Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2017
Feb 07,2018: Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Aptose Biosciences Inc – Key Facts 5
Aptose Biosciences Inc – Key Employees 6
Aptose Biosciences Inc – Key Employee Biographies 7
Aptose Biosciences Inc – Major Products and Services 8
Aptose Biosciences Inc – History 9
Aptose Biosciences Inc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Aptose Biosciences Inc – Business Description 14
Aptose Biosciences Inc – Corporate Strategy 15
Aptose Biosciences Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
Aptose Biosciences Inc – Strengths 16
Aptose Biosciences Inc – Weaknesses 17
Aptose Biosciences Inc – Opportunities 18
Aptose Biosciences Inc – Threats 19
Aptose Biosciences Inc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Aptose Biosciences Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
May 10, 2018: Aptose Reports Results for the First Quarter Ended March 31, 2018 30
Mar 27, 2018: Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2017 32
Feb 07, 2018: Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus 34
Nov 14, 2017: Aptose Reports Results for the Third Quarter Ended September 30, 2017 35
Aug 08, 2017: Aptose Reports Results for the Second Quarter Ended June 30, 2017 37
May 11, 2017: Aptose Reports Results for the First Quarter Ended March 31, 2017 39
Mar 28, 2017: Aptose Reports Fourth Quarter and Year End 2016 Results 41
Mar 27, 2017: Aptose Announces Planned Departure of Chief Business Officer 45
Section 6 – Appendix 46
Methodology 46
Ratio Definitions 46
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Aptose Biosciences Inc, Key Facts 5
Aptose Biosciences Inc, Key Employees 6
Aptose Biosciences Inc, Key Employee Biographies 7
Aptose Biosciences Inc, Major Products and Services 8
Aptose Biosciences Inc, History 9
Aptose Biosciences Inc, Other Locations 12
Aptose Biosciences Inc, Key Competitors 20
Aptose Biosciences Inc, Ratios based on current share price 21
Aptose Biosciences Inc, Annual Ratios 22
Aptose Biosciences Inc, Annual Ratios (Cont...1) 23
Aptose Biosciences Inc, Interim Ratios 25
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Aptose Biosciences Inc, Recent Deals Summary 29
Currency Codes 46
Capital Market Ratios 46
Equity Ratios 47
Profitability Ratios 47
Cost Ratios 48
Liquidity Ratios 48
Leverage Ratios 49
Efficiency Ratios 49

List of Figures
Aptose Biosciences Inc, Performance Chart (2013 - 2017) 24
Aptose Biosciences Inc, Ratio Charts 26
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Aptose Biosciences Inc (APTO):企業の財務・戦略的SWOT分析(Aptose Biosciences Inc (APTO) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆